Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

1. de Vries, E.G.E.
2. Rüschoff, J.
3. Lolkema, M.
4. Tabernero, J.
5. Gianni, L.
6. Voest, E.
7. de Groot, D.J.A.
8. Castellano, D.
9. Erb, G.
10. Naab, J.
11. Donica, M.
12. Deurloo, R.
13. van der Heijden, M.S.
14. Viale, G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/CAM4.5893 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus